ArQule Message Board - Msg: 10680308

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule

ARQL 20.00

0.0%

Jan 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Herc who wrote (358)	7/27/1999 9:00:00 PM
From: tommysdad	Read Replies (2) of 399

Calling ARQL an embryonic SEPR is far-fetched in the extreme. The business models are completely different, the science is completely different, the partnerships are completely different. ARQL will never, ever, ever, generate the kind of revenues SEPR has the potential to. Please note that I am long ARQL and like the company. But for very different reasons than SEPR (which I also like and am long). And chemistry is my strong suit.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next